Public HealthSARS-CoV-2 Trends: Recent Variants, What’s to Come, and What’s Still NeededOctober 1, 2021
Public HealthHow DNA-testing startup Helix became one of the nation's leading coronavirus tracking labsJune 14, 2021
Company NewsHelix Announces $50 Million Series C Funding to Continue Acceleration into Clinical Population Genomics and COVID-19 Viral SurveillanceJune 3, 2021
Public HealthEvidence of “double mutant” substitutions E484Q and L452R in the B.1.429 lineage suggest convergent evolution of immune escape mutationsMay 4, 2021
Public HealthExperts predicted the UK variant would become dominant in the US by March. So, is it?March 31, 2021
Public HealthCOVID-19 strain first spotted in U.K. spreading quickly, San Diego scientists reportMarch 31, 2021
Public HealthHelix Launches a COVID-19 Viral Surveillance Dashboard to Track Emergence and Prevalence of New SARS-CoV-2 VariantsJanuary 21, 2021
Public HealthIllumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK Variant (B.1.1.7) in the US and Develop National Surveillance InfrastructureJanuary 15, 2021
Helix ResearchUpdate on the Helix, Illumina surveillance program: B.1.1.7 variant of SARS-CoV-2, first identified in the UK, spreads further into the USJanuary 11, 2021
